BIOMERICA INC Advertising Expense
BIOMERICA INC (BMRA) reported Advertising Expense of $35.00 thousand for the 12-month period ending 2026-05-31, per its 10-K filed 2026-08-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AdvertisingExpense · last filed 2026-08-31
- BIOMERICA INC advertising expense for the quarter ending 2026-05-31 was $10.00K, a 100.00% increase year-over-year.
- BIOMERICA INC advertising expense for the quarter ending 2026-02-28 was $8.00K, a 100.00% increase year-over-year.
- BIOMERICA INC advertising expense for the quarter ending 2025-11-30 was $7.00K, a 41.67% decline year-over-year.
- BIOMERICA INC advertising expense for the quarter ending 2025-08-31 was $9.00K, a 35.71% decline year-over-year.
- BIOMERICA INC advertising expense for fiscal 2026 was $35.00K, a 0.00% change from fiscal 2025.
- BIOMERICA INC advertising expense for fiscal 2025 was $35.00K, a 65.35% decline from fiscal 2024.
- BIOMERICA INC advertising expense for fiscal 2024 was $101.00K, a 35.26% decline from fiscal 2023.
- BIOMERICA INC advertising expense for fiscal 2023 was $156.00K, a 105.26% increase from fiscal 2022.
| Period end | Advertising Expense 3 month | Advertising Expense 6 month | Advertising Expense 9 month | Advertising Expense 12 month | Advertising Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2026-05-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-31 | $18.00K derived: sum of 2 quarters · filed 2026-08-31 | $25.00K derived: sum of 3 quarters · filed 2026-08-31 | $35.00K 10-K · filed 2026-08-31 | |
| 2026-02-28 | $8.00K 10-Q · filed 2026-04-13 | $15.00K derived: sum of 2 quarters · filed 2026-04-13 | $25.00K 10-Q · filed 2026-04-13 | $29.00K derived: sum of 4 quarters · filed 2026-08-31 | |
| 2025-11-30 | $7.00K 10-Q · filed 2026-01-14 | $17.00K 10-Q · filed 2026-01-14 | $21.00K derived: sum of 3 quarters · filed 2026-08-31 | $25.00K derived: sum of 4 quarters · filed 2026-08-31 | |
| 2025-08-31 | $9.00K 10-Q · filed 2025-10-14 | $14.00K derived: sum of 2 quarters · filed 2026-08-31 | $18.00K derived: sum of 3 quarters · filed 2026-08-31 | $30.00K derived: sum of 4 quarters · filed 2026-08-31 | |
| 2025-05-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-31 | $9.00K derived: sum of 2 quarters · filed 2026-08-31 | $21.00K derived: sum of 3 quarters · filed 2026-08-31 | $35.00K 10-K · filed 2026-08-31 | |
| 2025-02-28 | $4.00K 10-Q · filed 2026-04-13 | $16.00K derived: sum of 2 quarters · filed 2026-04-13 | $30.00K 10-Q · filed 2026-04-13 | $51.00K derived: sum of 4 quarters · filed 2026-04-13 | |
| 2024-11-30 | $12.00K 10-Q · filed 2026-01-14 | $26.00K 10-Q · filed 2026-01-14 | $47.00K derived: sum of 3 quarters · filed 2026-01-14 | $72.00K derived: sum of 4 quarters · filed 2026-01-14 | |
| 2024-08-31 | $14.00K 10-Q · filed 2025-10-14 | $35.00K derived: sum of 2 quarters · filed 2025-10-14 | $60.00K derived: sum of 3 quarters · filed 2025-10-14 | $86.00K derived: sum of 4 quarters · filed 2025-10-14 | |
| 2024-05-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-29 | $46.00K derived: sum of 2 quarters · filed 2025-08-29 | $72.00K derived: sum of 3 quarters · filed 2025-08-29 | $101.00K 10-K · filed 2025-08-29 | |
| 2024-02-29 | $25.00K 10-Q · filed 2025-04-14 | $51.00K derived: sum of 2 quarters · filed 2025-04-14 | $80.00K 10-Q · filed 2025-04-14 | $150.00K derived: sum of 4 quarters · filed 2025-04-14 | |
| 2023-11-30 | $26.00K 10-Q · filed 2025-01-14 | $56.00K 10-Q · filed 2025-01-14 | $125.00K derived: sum of 3 quarters · filed 2025-01-14 | $176.00K derived: sum of 4 quarters · filed 2025-01-14 | |
| 2023-08-31 | $30.00K 10-Q · filed 2024-10-15 | $99.00K derived: sum of 2 quarters · filed 2024-10-15 | $150.00K derived: sum of 3 quarters · filed 2024-10-15 | $168.00K derived: sum of 4 quarters · filed 2024-10-15 | |
| 2023-05-31 | $69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-28 | $120.00K derived: sum of 2 quarters · filed 2024-08-28 | $138.00K derived: sum of 3 quarters · filed 2024-08-28 | $156.00K 10-K · filed 2024-08-28 | |
| 2023-02-28 | $51.00K 10-Q · filed 2024-04-12 | $69.00K derived: sum of 2 quarters · filed 2024-04-12 | $87.00K 10-Q · filed 2024-04-12 | ||
| 2022-11-30 | $18.00K 10-Q · filed 2024-01-16 | $36.00K 10-Q · filed 2024-01-16 | |||
| 2022-08-31 | $18.00K 10-Q · filed 2023-10-12 | ||||
| 2022-05-31 | $76.00K 10-K · filed 2023-08-25 | ||||
| 2021-08-31 | $8.00K 10-Q · filed 2022-10-13 | ||||
| 2021-05-31 | $10.00K 10-K · filed 2022-08-29 | $10.07K 10-K · filed 2021-08-27 | |||
| 2020-05-31 | $174.00 10-K/A · filed 2021-10-14 | ||||
| 2019-05-31 | $0.00 10-K · filed 2020-08-31 | ||||
| 2018-05-31 | $1.00K 10-K · filed 2019-08-29 | ||||
| 2017-05-31 | $7.00K 10-K · filed 2018-08-29 | ||||
| 2016-05-31 | $2.00K 10-K · filed 2017-08-29 | ||||
| 2015-05-31 | $6.00K 10-K · filed 2016-08-29 | ||||
| 2014-05-31 | $8.00K 10-K · filed 2015-08-31 | ||||
| 2013-05-31 | $6.00K 10-K · filed 2014-08-29 | ||||
| 2012-05-31 | $8.00K 10-K · filed 2013-08-29 | ||||
| 2011-05-31 | $9.00K 10-K · filed 2012-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |